Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0)

Charlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, Christian Barrere, Sarah Bahraoui, Claudia Terraza, Gautier Tejedor, Anne Vincent, Patricia Luz-Crawford, Kantapich Kongpol, Sarawut Kumphune, Christophe Piot, Joel Nargeot, Christian Jorgensen, Farida Djouad, Stéphanie Barrere-Lemaire*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The original article contained errors in the attribution of affiliations which have since been corrected.

Original languageEnglish
Article number338
JournalStem Cell Research and Therapy
Volume13
Issue number1
DOIs
StatePublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

Fingerprint

Dive into the research topics of 'Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0)'. Together they form a unique fingerprint.

Cite this